Write what you believe about your stocks; every morning the cited record grades it: supported, challenged, or untouched. Never opinions.

Development · 28 Oct 2026

TORNTPHARM, full dossier

PM IST Mumbai: Torrent Pharma reported a 9.6 per cent year-on-year (YoY) decline in net profit at Rs 534 crore for the second quarter ended this year. However, operating revenue jumped 50.8 per cent to Rs 4,979 crore, compared to Rs 3,302 crore last year, driven by incremental gains from JB Pharma.

1 publisher has reported this development. Each act of reporting is below, cited.

The record

PM IST Mumbai: Torrent Pharma reported a 9.6 per cent year-on-year (YoY) decline in net profit at Rs 534 crore for the second quarter ended this year. However, operating revenue jumped 50.8 per cent to Rs 4,979 crore, compared to Rs 3,302 crore last year, driven by incremental gains from JB Pharma.

indiatimes.com27 Oct 2026

A single act of reporting so far, corroborating sources join this record as they publish.

Torrent Pharmaceuticals

₹4,691.20

▲ +0.45%

Close (EOD), as of 16 Nov 2026 · source

Torrent Pharmaceuticals: results, dividends, orders, the full cited record →

Every claim carries its citation

This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.